|

OSU6162 Clinical Trials

2 actively recruiting trials

Also known as: OSU-6162, PNU-96391

Pipeline

Phase 2: 2

Top Sponsors

  • Göteborg University2

Indications

  • Depression2
  • Recurrent Depressive Disorder1
  • Recurrent Depression1
  • Depressive Episode1
  • Depressive Disorder, Treatment-Resistant1

Other2 trials

OSU6162 as add-on in SSRI/SNRI-resistant Depression
Phase 2
OSU6162 in Bipolar Depression (OBID)
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.